Evidence map›Paper›PMID 31622111›Full record

ArticleAmerican journal of respiratory cell and molecular biology2020

A Focus on "Eye on" Channels in Pulmonary Fibrosis.

Rachel G Scheraga, Mitchell A Olman

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. mExperimental and therapeutic medicine · 2026
    Review
  2. Article
  3. mMolecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  4. Update in Interstitial Lung Disease 2020.American journal of respiratory and critical care medicine · 2021
    Review
  5. Mechanotransduction in Wound Healing and Fibrosis.Journal of clinical medicine · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Rachel G ScheragaRespiratory Instituteand.ORCID 0000-0001-5113-543X
Mitchell A OlmanRespiratory Instituteand.ORCID 0000-0003-3262-3598

Funding

TRPV4-PI3K Axis Mediates Pulmonary and Cardiac FibrosisR01HL133721 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI OLMAN, MITCHELL ALAN, PRASAD, SATHYAMANGLA V · 2017 to 2020
$2.2M
Myofibroblast differentiation and fibrosis are mediated by TRPV4 mechanosensingR01HL119792 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI OLMAN, MITCHELL ALAN · 2014 to 2017
$1.6M
Transient Receptor Potential Vanilloid 4 (TRPV4) mediates the host defense and lung injury response to bacterial pneumoniaK08HL133380 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI SCHERAGA, RACHEL GREENBERG · 2016 to 2020
$809k
NHLBI NIH HHS K08 HL133380NHLBI NIH HHS R01 HL119792NHLBI NIH HHS R01 HL133721
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Large-Conductance Calcium-Activated Potassium ChannelsPulmonary FibrosisCell DifferentiationHumansMyofibroblastsLarge-Conductance Calcium-Activated Potassium Channels

Identifiers

PMID31622111
PMCPMC6993549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.